Prakash Gowd brings over 25 years of experience in executive management, strategic business analysis, corporate development, financing, and capital markets focused on the healthcare and biopharma sectors. He is currently Senior Vice President, Corporate Development at Novamind Inc., a public mental healthcare and psychedelic medicine company, where he leads corporate strategy, business development and M&A initiatives. Previously, Mr. Gowd was President and Co-founder of Lobo Genetics, a genetic testing company, where he played pivotal roles in the development of the company and its evolution through challenging conditions, culminating in the sale to a third party. His extensive capital markets experience was attained through multiple senior level equity research roles with CIBC World Markets, National Bank Financial, and Canaccord Capital, where he focused exclusively on financing and investments in healthcare, biotech, medical device, and specialty pharma companies. Mr. Gowd held progressive positions in commercial operations at GlaxoSmithKline, and specialized in marketing and new product development consulting for clients in the pharmaceutical industry. He served as Audit Chair and Director of Isotechnika Pharma Inc., the predecessor company to Aurinia Pharmaceuticals. Mr. Gowd holds an MBA from McGill University, a BSc Pharmacy from the University of British Columbia, and a Chartered Director designation.
Enter your email to get the latest developments on N-Zyme, including our research, clinical trials and corporate reports.